SCHEMBL6274839

SCHEMBL6274839

NC(=O)CNC(=O)C1CCCC1.O=C(O)C1CCCC1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX1 P07099 1/20 0.47
SMN1; SMN2 Q16637 3/20 0.46
HSD17B10 Q99714 1/20 0.46
DPP4 P27487 2/20 0.42
PREP P48147 2/20 0.42
FAP Q12884 2/20 0.42
ALDH1A1 P00352 2/20 0.41
USP2 O75604 2/20 0.41
HPGD P15428 1/20 0.41
NAAA Q02083 1/20 0.41
HDAC8 Q9BY41 1/20 0.41
HDAC6 Q9UBN7 1/20 0.41
PSMB5 P28074 2/20 0.40
NPC1 O15118 1/20 0.39
PKM P14618 1/20 0.39
EPHX2 P34913 1/20 0.39
RAB9A P51151 1/20 0.39
PLG P00747 1/20 0.38
PLAT P00750 1/20 0.38
LMNA P02545 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6274117 0.92 EPHX1 (0.53) EPHX1SMN1; SMN2HSD17B10DPP4PREP
SCHEMBL26583876 0.88 EPHX1 (0.48) EPHX1SMN1; SMN2HSD17B10DPP4PREP
SCHEMBL6271399 0.84 PLG (0.39) EPHX1SMN1; SMN2HSD17B10PSMB5PLG
SCHEMBL6274792 0.79 AAK1 (0.40) EPHX1SMN1; SMN2HSD17B10ALDH1A1USP2
SCHEMBL1651905 0.78 EPHX1 (0.55) EPHX1SMN1; SMN2HSD17B10DPP4PREP
SCHEMBL1449384 0.76 EPHX1 (0.59) EPHX1SMN1; SMN2HSD17B10DPP4PREP
SCHEMBL15865900 0.76 EPHX1 (0.59) EPHX1SMN1; SMN2HSD17B10DPP4PREP
SCHEMBL6271761 0.76 KMT2A (0.41) EPHX1SMN1; SMN2HSD17B10ALDH1A1NAAA
SCHEMBL845001 0.74 ALDH1A1 (0.52) EPHX1SMN1; SMN2HSD17B10DPP4PREP
SCHEMBL19745369 0.73 EPHX1 (0.59) EPHX1SMN1; SMN2HSD17B10DPP4PREP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1606244-A2 CYCLOALKYLAMIDES AND THEIR THERAPEUTIC USE AS ANTIEPILEPTIC AND ANTICONVULSANT Abbott Laboratories (US) 2005-12-21 EP disclosed
WO-2004037769-A2 CYCLOALKYLAMIDES AND THEIR THERAPEUTIC USE AS ANTIEPILEPTIC AND ANTICONVULSANT ABBOTT LABORATORIES (US) 2004-05-06 WO disclosed